Cargando…
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments
SIMPLE SUMMARY: Castration-resistant prostate cancer (CRPC) remains a significant medical challenge, even with recent advancements in diagnosis and treatment. To improve patient outcomes, it is important to understand the underlying mechanisms of resistance to treatments and develop new therapeutic...
Autores principales: | Le, Thi Khanh, Duong, Quang Hieu, Baylot, Virginie, Fargette, Christelle, Baboudjian, Michael, Colleaux, Laurence, Taïeb, David, Rocchi, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605314/ https://www.ncbi.nlm.nih.gov/pubmed/37894414 http://dx.doi.org/10.3390/cancers15205047 |
Ejemplares similares
-
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity
por: Cherif, Chaïma, et al.
Publicado: (2021) -
Nucleoside-Lipid-Based Nanoparticles for Phenazine Delivery: A New Therapeutic Strategy to Disrupt Hsp27-eIF4E Interaction in Castration Resistant Prostate Cancer
por: Ziouziou, Hajer, et al.
Publicado: (2021) -
Current Treatment Strategies for Castration-Resistant Prostate Cancer
por: Kim, Se Joong, et al.
Publicado: (2011) -
Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2017) -
Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castration-resistant prostate cancer treatment
por: Ziouziou, Hajer, et al.
Publicado: (2018)